AbbVie’s DECNUPAZ™ got Approval from FDA: First and Only Antibody-Drug Conjugate (ADC) Treatment
AbbVie (NYSE: ABBV) announced that the U.S. Food and Drug Administration (FDA) has approved DECNUPAZTM (pivekimab sunirine-pvzy), first and only antibody-drug conjugate (ADC) drug for the treatment of Blastic Plasmacytoid Dendritic Cell...
A Proud Moment for Bengal: Kolkata to Host International Day of Yoga 2026 on June 21
In a moment of pride for West Bengal, Kolkata has been officially selected as the host city for the main national celebration of the...
Bristol Myers Squibb Secures Dual Regulatory Wins for Opdivo® in Classical Hodgkin Lymphoma
Bristol Myers Squibb (NYSE: BMY) announced that Opdivo® (nivolumab) has received approval for two new classical Hodgkin Lymphoma (cHL) indications in the U.S. and...
Lupin Secures ANDA Approval, Set to Enter the Chinese Market
Indian global pharma giant on 22 May, though a press release has announced that the company has received the China's National Medical Products Administration’s (NMPA) approval of Abbreviated New Drug Application (ANDA) for its Oseltamivir...
Alembic Receives USFDA Approval for Levothyroxine Sodium Tablets
Alembic Pharmaceuticals Limited announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application...
Commitment Towards Precise Diagnostic Services: Metropolis Healthcare Launches New Greenfield Laboratoryin Panjab
On 22nd May 2026, the Metropolis Healthcare, one of Indias leading diagnostics chain launches their new “Greenfield Laboratory” in Panjab’s Amritsar. The inauguration was graced by Dr. Anumeet Singh Grover, renowned gastroenterologist along with other renowned medical professionals across the country and...